echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Injection enters a new round of centralized procurement list, 2020 consistency evaluation tug-of-war begins

    Injection enters a new round of centralized procurement list, 2020 consistency evaluation tug-of-war begins

    • Last Update: 2020-01-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Years and weeks turn around 2020 has quietly arrived The past 2019 is the year of policy implementation Volume purchase, negotiation and access of the new version of medical insurance catalog, and the implementation of key monitoring drug catalog have been officially implemented, especially the expansion of centralized drug purchase The second batch of volume purchased drugs at the end of the year ignites a new round of highlight moment in the pharmaceutical industry at the end of 2019, which is directly related to it People in the industry pay close attention to the consequent evaluation As of January 2, 2020, there are 1728 acceptance numbers of CDE acceptance consistency evaluation (457 varieties of 474 enterprises, calculated by supplementary application, the same below), and 327 acceptance numbers (127 varieties) that have passed the consistency evaluation As a whole, consistency evaluation in 2019 is a compulsory course for generic drugs gradually At the end of 2019 in December, it is also the sprint stage of consistency evaluation In December, the expected acceptance number of consistency evaluation reached another small climax, reaching 110 (72 varieties), and the number of reading applications ranked the third in the month since the implementation of consistency evaluation See the following figure for details: Among them, it is worth noting that in December, the consistency evaluation of the application form of injection power, 50.97% of the acceptance number is the injection, at present, the relevant documents of generic injection are gradually published, especially the successive publication of the injection reference preparation, especially the paclitaxel for injection (albumin binding type) is the only injection purchased in the second batch of belt volume, and the variety is currently only available It can be seen that the consistency evaluation of Ouyi and Jiangsu Hengrui Pharmaceutical Co., Ltd has passed the consistency evaluation Therefore, it is expected that in 2020, the consistency evaluation will mainly stage the injection competition It is worth mentioning that the most popular consistency evaluation variety of injection in December is ambroxol hydrochloride injection, which ranks first both in the number of acceptance number of variety application and the number of enterprises applying for variety application, and 6 acceptance numbers of 3 enterprises are accepted together Up to now, 22 Acceptance numbers of 12 enterprises have been accepted, and at the same time, it is the current injection variety Consistency evaluation is one of the most competitive varieties The application acceptance number is next to the first ceftriaxone sodium for injection In December, the application acceptance was eye-catching, and it was even more exciting to pass the consistency evaluation In December, there were 14 varieties of 16 enterprises that had been evaluated, among which the number of multiple varieties of enterprises had reached 10 or was about to exceed 10, and in this month's new round of volume procurement, the number of winning enterprises could reach up to 6, especially amoxicillin capsule, azithromycin tablet, cephra that had passed in December Ding capsule was in the range of the second batch of volume purchase, and successfully obtained the admission ticket at the end of the year Detailed form of conformity assessment in December Amoxicillin capsule is the most commonly used broad-spectrum oral penicillin at present It is the variety with the largest number of application acceptance for consistency evaluation, reaching 47, involving 37 enterprises, of which 10 enterprises have reviewed the drug with different specifications Recently, the state procurement requires all regions to submit the relevant data of the second batch of varieties to be collected, including amoxicillin's mouth in 33 varieties Take regular release form It can be imagined that this variety will be in a fierce competition in the new round of centralized mining Details of consistency evaluation of Amoxicillin Capsules In addition, 26 varieties have been approved in December and will be evaluated soon Among them, azithromycin, paracetamol, Cefalexin, isoniazid, indapamide and other corresponding varieties of oral regular release dosage forms are new drugs for centralized purchase Whether they can be evaluated before the new round of centralized purchase official bid opening and obtain access qualification remains to be seen Details of approval of consistency assessment in December
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.